3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Multiple Myeloma
70
Leukemia, Lymphocytic, Chronic, B-Cell
26
Lymphoma, Mantle-Cell
15
Lymphoma, Follicular
15
Lymphoma, Large B-Cell, Diffuse
14
Leukemia, Myeloid, Acute
14
Lymphoma, B-Cell, Marginal Zone
13
Lymphoma, Non-Hodgkin
12
Recurrence
11
Neoplasms, Plasma Cell
10
Lymphoma
10
Myelodysplastic Syndromes
9
Hodgkin Disease
8
Neoplasms
7
Leukemia
7
Burkitt Lymphoma
7
Waldenstrom Macroglobulinemia
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, T-Cell, Cutaneous
6
Lymphoma, B-Cell
6
Sezary Syndrome
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Mycosis Fungoides
4
Lymphoma, T-Cell, Peripheral
4
Lymphoma, Large-Cell, Immunoblastic
4
Astrocytoma
4
Smoldering Multiple Myeloma
3
Prostatic Neoplasms
3
Oligodendroglioma
3
Melanoma
3
Interventions
venetoclax
6
Azacitidine
6
Cytarabine
5
fludarabine
4
Methotrexate
3
fludarabine phosphate
2
aldesleukin
2
RO6839921
2
Mitoxantrone
2
Interleukin-2
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Decitabine
2
Dasatinib
2
zileuton
1
thymoglobulin
1
spartalizumab
1
sabatolimab
1
quizartinib
1
pulrodemstat besilate
1
posaconazole
1
plerixafor
1
gilteritinib
1
etoposide phosphate
1
emvododstat
1
daratumumab
1
blinatumomab
1
Sorafenib
1
Sirolimus
1
Panobinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Leukemia, Myeloid
×
Lenalidomide
×
Clear all
NCT02370888
2020-01-27
UF-BMT-MRD-101
University of Florida
Phase 1
Terminated
11 enrolled
3 charts